Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 4:8:617789.
doi: 10.3389/fvets.2021.617789. eCollection 2021.

Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis

Affiliations

Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis

Cemal Orhan et al. Front Vet Sci. .

Abstract

Osteoarthritis (OA) is an age-related joint disease that includes gradual disruption of the articular cartilage and the resulting pain. The present study was designed to test the effects of undenatured type II collagen (UC-II®) on joint inflammation in the monoiodoacetate (MIA) OA model. We also investigated possible mechanisms underlying these effects. Female Wistar rats were divided into three groups: (i) Control; (ii) MIA-induced rats treated with vehicle; (iii) MIA-induced rats treated with UC-II (4 mg/kg BW). OA was induced in rats by intra-articular injection of MIA (1 mg) after seven days of UC-II treatment. UC-II reduced MIA-induced Kellgren-Lawrence scoring (53.3%, P < 0.05). The serum levels of inflammatory cytokines [IL-1β (7.8%), IL-6 (18.0%), TNF-α (25.9%), COMP (16.4%), CRP (32.4%)] were reduced in UC-II supplemented group (P < 0.0001). In the articular cartilage, UC-II inhibited the production of PGE2 (19.6%) and the expression of IL-1β, IL-6, TNF-a, COX-2, MCP-1, NF-κB, MMP-3, RANKL (P < 0.001). The COL-1 and OPG levels were increased, and MDA decreased in UC-II supplemented rats (P < 0.001). UC-II could be useful to alleviate joint inflammation and pain in OA joints by reducing the expression of inflammatory mediators.

Keywords: MIA; Nf-κB; UC-II; inflammation; osteoarthritis.

PubMed Disclaimer

Conflict of interest statement

VJ an employee of Lonza Consumer Health (NJ, USA). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Effect of undenatured type II collagen (UC-II) supplementation on serum interleukin-1β (IL-1β; A), interleukin-6 (IL-6; B), tumor necrosis factor α (TNF-α; C), cartilage oligometrix matrix protein (COMP; D), c-reactive protein (CRP; E), prostaglandin E2 (PGE2; F), and osteocalcin (OCN; G) levels in monosodium iodoacetate (MIA) induced osteoarthritis rats (n = 7). The bars represent the mean and standard deviation of data. ANOVA and Tukey's post-hoc test were used to compare the results among different treatment groups. Statistical significance between groups is shown by ***P < 0.001 compared to the control group and ##P < 0.01, ###P < 0.001 compared to the MIA group.
Figure 2
Figure 2
Effect undenatured type II collagen (UC-II) on serum malondialdehyde (MDA; A), superoxide dismutase (SOD; B), catalase (CAT; C), and glutathione peroxidase (GSHPx; D) levels in monosodium iodoacetate (MIA) induced osteoarthritis rats (n = 7). The bars represent the mean and standard deviation of data. ANOVA and Tukey's post-hoc test were used to compare the results among different treatment groups. Statistical significance between groups is shown by: ***P < 0.001 as compared to the control group and #P < 0.05 as compared to MIA group.
Figure 3
Figure 3
Effect undenatured type II collagen (UC-II) on stride length (C), paw area (D), and paw width (E) in monosodium iodoacetate (MIA) induced osteoarthritis rats (n = 7). Representative measures of stride length (A), paw area (B) and paw width (B) are shown. The bars represent the mean and standard deviation of data. ANOVA and Tukey's post-hoc test were used to compare the results among different treatment groups. Statistical significance between groups is shown by **P < 0.01, ***P < 0.001 compared to the control group and ## P < 0.01 compared to the MIA group.
Figure 4
Figure 4
Effect of undenatured type II collagen (UC-II) on knee swelling (A) and right knee joint diameter (B) in monosodium iodoacetate (MIA) induced osteoarthritis rats (n = 7). The bars represent the mean and standard deviation of data. ANOVA and Tukey's post-hoc test were used to compare the results among different treatment groups. Statistical significance between groups is shown by: *P < 0.05 as compared to the control group.
Figure 5
Figure 5
Effect of undenatured type II collagen (UC-II) on the knee joint radiographic and histopathologic findings in monosodium iodoacetate (MIA) induced osteoarthritis rats (n = 7). Representative radiographic (A) and histopathologic (B) images obtained at the end of the experiment are shown. Kellgren-Lawrence and Mankin scores were shown in (C) and (D), respectively. The bars represent the mean and standard deviation of data. Mann-Whitney U test were used to compare the results among different treatment groups. Statistical significance between groups is shown by: #P < 0.05 as compared to the MIA group.
Figure 6
Figure 6
Effect of undenatured type II collagen (UC-II) on knee joint protein expression of interleukin-1β (IL-1β; A), interleukin-6 (IL-6; B), tumor necrosis factor α (TNF-α; C), interferon regulatory factor 7 (IRF7; D), cyclooxygenase-2 (COX-2; E), nuclear factor-kappa B kinase subunit gamma (IKK-γ; F), monocyte chemoattractant protein-1 (MCP-1; G), and nuclear factor kappa B (NF-κB; H) levels in monosodium iodoacetate (MIA) induced osteoarthritis rats (n = 7). The densitometric analysis of the relative intensity according to the control group of the western blot bands was performed with β-actin normalization to ensure equal protein loading. Blots were repeated at least three times (n = 3) and representative blots are shown. The bars represent the mean and standard deviation of data. ANOVA and Tukey's post-hoc test were used to compare the results among different treatment groups. Statistical significance between groups is shown by: **P < 0.01, ***P < 0.001 as compared to control group and, ### P < 0.001 as compared to MIA group.
Figure 7
Figure 7
Effect of undenatured type II collagen (UC-II) on knee joint protein expression of metalloproteinase 3 (MMP-3; A), collagen type 1 (COL-1; B), osteoprotegerin (OPG; C), and receptor activator of NF-κB ligand (RANKL; D) levels in monosodium iodoacetate (MIA) induced osteoarthritis rats (n = 7). The densitometric analysis of the relative intensity according to the control group of the western blot bands was performed with β-actin normalization to ensure equal protein loading. Blots were repeated at least three times (n = 3) and representative blots are shown. The bars represent the mean and standard deviation of data. ANOVA and Tukey's post-hoc test were used to compare the results among different treatment groups. Statistical significance between groups is shown by: ***P < 0.001 as compared to the control group and, ### P < 0.001 as compared to MIA group.

Similar articles

Cited by

References

    1. Mobasheri A, Rayman MP, Gualillo O, Sellam J, van der Kraan P, Fearon U. The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. (2017) 13:302–11. 10.1038/nrrheum.2017.50 - DOI - PubMed
    1. Glyn-Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Weinans H, et al. . Osteoarthritis. Lancet. (2015) 386:376–87. 10.1016/s0140-6736(14)60802-3 - DOI - PubMed
    1. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J-P, Fahmi H. Role of pro-inflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. (2011) 7:33–42. 10.1038/nrrheum.2010.196 - DOI - PubMed
    1. Elsaid KA, Chichester CO. Review: Collagen markers in early arthritic diseases. Clinica Chimica Acta. (2006) 365:68–77. 10.1016/j.cca.2005.09.020 - DOI - PubMed
    1. Yuan G-H, Masuko-Hongo K, Kato T, Nishioka K. Immunologic intervention in the pathogenesis of osteoarthritis. Arthritis Rheumatol. (2003) 48:602–11. 10.1002/art.10768 - DOI - PubMed